-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614.P1.52 614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis: Poster I

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Xue Chen, MD1*, Lili Yuan, MD2*, Xiaoli Ma, MD1*, Fang Wang, MD1*, Yang Zhang, MD1*, Panxiang Cao, MD2*, Jiancheng Fang, MD3*, Tong Wang, MD2*, Jiaqi Chen, PhD2*, Xiaosu Zhou, PhD4* and Hongxing Liu, MD2,5

1Department of Clinical Laboratory, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
3Department of Clinical Laboratory, Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, China
4Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, AL, China
5Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China

Kathryn Kimi Shimamoto1,2*, Arda Arda Karaoglu1,2*, Zachary Chan3*, Giorgia Giordano, BE4*, Bartholomew Eisfelder, PhD4*, Jason Xiaojun Cheng, MD, PhD5, Hamed Youshanlouei4*, Syed Shah4*, Anand Ashwin Patel, MD6, Adam S. Duvall, MD6, Francis Burrows, PhD7*, Linda Kessler, BA7*, Michael W Drazer, MD, PhD8, Olatoyosi Odenike, MD6, Michael J. Thirman, MD4, Wendy Stock, MD6 and Caner Saygin, MD6

1Section of Hematology/Oncology, The University of Chicago, Chicago, IL, Chicago, IL
2Contributed equally, Chicago
3Cornell University, Ithaca
4Section of Hematology/Oncology, The University of Chicago, Chicago, IL, Chicago
5Department of Pathology, The University of Chicago, Chicago, IL, Chicago
6Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
7Kura Oncology, Carlsbad
8Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL

Ryo Nakagawa1,2*, Yosuke Isobe3*, Ari Itoh-Nakadai4*, Haruki Uchino3*, Minggao Liang5*, Akiko Kaneko4*, Kaori Sato4*, Mariko Tomizawa-Murasawa4*, Saera Fujiki4*, Emi Kanamaru4*, Hanae Amitani6*, Mikiko Endo6*, Shinsuke Takagi, MD, PhD7*, Naoyuki Uchida7, Shuichi Taniguchi, MD7*, Yukihide Momozawa6*, Yoriko Saito4, Makoto Arita3*, Hideo Harigae, MD, PhD1 and Fumihiko Ishikawa4

1Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
2Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Kawasaki, KAN, Japan
3Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
4Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
5Laboratory for Applied Computational Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
6Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
7Department of Hematology, Toranomon Hospital, Tokyo, Japan

Hermione E Allen1*, Andrew McIntyre, PhD2*, Jesus Gutierrez-Abril, PhD3*, Amy A Kirkwood, MSc4*, Daniel Leongamornlert, PhD5*, Rodothea Amerikanou, MBBChir1*, Emily A Cutler, MSc1*, Aditi Dey, PhD1*, Richard Burt, PhD, FRCPath, MRCP6,7*, Ronjon Chakraverty2* and Adele Kay Fielding, MBBS, PhD1,8

1Cancer Institute, University College London, London, United Kingdom
2Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
3Memorial Sloan Kettering Cancer Centre, New York City
4Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom
5Cancer, Ageing and Somatic Mutation (CASM), Wellcome Sanger Institute, Hinxton, United Kingdom
6Imperial College London, London, United Kingdom
7The Francis Crick Institute, London, United Kingdom
8Hull York Medical School, University of York, York, United Kingdom

Venkata Sesha Sai Abhinav Ayyadevara, PhD, MS1*, Gerald Wertheim, MD, PhD2*, John Chukinas3*, Joseph Loftus3*, Sung June Lee4*, Anil Kumar, PhD5*, Srividya Swaminathan, PhD6, Rahul S Bhansali, MD7, Wayne Childers8*, Huimin Geng, PhD9*, Thomas A Milne10, Xianxin Hua, MD, PhD11*, Kathrin M. Bernt, MD3, Thierry Besson12*, Junwei Shi, PhD13*, John D. Crispino, PhD14, Martin P Carroll, MD2, Sarah K Tasian, MD15 and Christian Hurtz, PhD16

1Division of Cancer Sciences, Loma Linda University, Philadelphia, PA
2Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
3Children's Hospital of Philadelphia, Philadelphia, PA
4City of Hope Beckman Research Institute, Duarte, CA
5City of Hope, Duarte, CA
6City of Hope - BRC, Duarte, CA
7Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
8Temple University, Philadelphia, PA
9Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
10Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
11University of Pennsylvania, Philadelphia, PA
12Normandie University, Rouen, FRA
13Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
14Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
15Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
16Division of Cancer Sciences, Loma Linda University, Loma Linda, CA

Ting Zhou, MD, PhD1*, Nicholas J. Short, MD2, Nitin Jain, MD2, Keyur P. Patel, MD, PhD3*, Elias Jabbour, MD2, Hagop M. Kantarjian, MD2, L. Jeffrey Medeiros, MD3 and Bryan Iorgulescu, MD, MPH, FCAP4*

1Memorial Sloan Kettering Cancer Center, New York
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Molecular Diagnostics Laboratory, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Cheng Wang, MAS1*, Jianfeng Li, PhD2*, Weiyang Liu, MD3*, Han Yan2*, Yuchen Yan2*, Lingling Zhao2*, Jiayi Ren, MD2*, Lijun Peng2*, Jiaojiao Zhang2*, Yuanfang Liu, MD, PhD2*, Xiangqin Weng, Master2*, Yongmei Zhu, PhD2*, Weiping Zhang, MD, PhD2*, Jie Xu, MD, PhD2, Duohui Jing2*, Jian-Qing Mi2* and Jin Wang, MD, PhD2*

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, TX, China
2Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, AL, China

Björn-Thore Hansen1,2,3*, Thomas Beder2,3,4*, Sören Döhle2*, Wencke Walter, PhD5, Malwine J Barz, PhD2,3,4*, Cecilia Bozzetti, MD2*, Johanna Horns2,3*, Axel Künstner6,7*, Alina M. Hartmann3,4,8*, Sören Franzenburg9*, Michael Wittig10*, Barbara Ritter11*, Stefan Schwartz, MD12*, Hauke Busch, PhD6,13*, Nikos Darzentas, PhD3,14*, Claudia Haferlach, MD15, Nicola Goekbuget, MD16, Monika Brüggemann, MD3,4,14*, Claudia D Baldus, MD3,4,14* and Lorenz Bastian2,3,4*

1(DFG, German Research Foundation): 413490537, Clinician Scientist Program in Evolutionary Medicine funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany
2Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
3University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany
4Clinical Research Unit CATCH ALL (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany
5Munich Leukemia Laboratory, Munich, Germany
6Medical Systems Biology Group, University of Lübeck, Lübeck, Germany
7University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Lübeck, Germany
8Department of Internal Medicine II (Hematology/Oncology), University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
9Institute for Clinical Molecular Biology, Kiel University, Kiel, DEU
10Institute for Clinical Molecular Biology, Kiel University, Kiel, Germany
11Department of Hematology, Oncology and Immunology, Klinikum Kassel, Kassel, Germany
12Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
13University Cancer Center Schleswig-Holstein, Lübeck, Germany
14Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
15MLL Munich Leukemia Laboratory, Munich, Germany
16Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany

Judith M. Boer, PhD1, Marco J. Koudijs, PhD2*, Lennart A. Kester, PhD2*, Edwin Sonneveld, PhD2*, Jayne Y. Hehir-Kwa, PhD1*, Simone Snijder, PhD3*, Esmé Waanders, PhD3*, Arjan Buijs, PhD4*, Valerie de Haas, PhD, MD1*, Inge M. van der Sluis, MD, PhD1, Rob Pieters, MD, PhD1, Monique L. den Boer, PhD1 and Bastiaan B.J. Tops1*

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Princess Maxima Center for pediatric oncology, Utrecht, Netherlands
3Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands
4Genome Diagnostics, University Medical Center Groningen, Groningen, Netherlands

Stefan Habringer1,2*, Iva Todorova2*, Frederik Herzberg, MD2*, Daniel Steiert2*, Arik Horne, PhD3*, Thomas Burmeister, MD, PhD4*, Simon Haas, PhD3*, Ulrich Keller1,2,5*, Monika Brüggemann, MD6,7*, Michaela Kotrova, MD, PhD6,8*, Claudia D Baldus, MD6,8*, Nicola Goekbuget, MD9,10, Martin Neumann, MD6,8* and Stefan Schwartz, MD1,2*

1German Cancer Consortium (DKTK) partner site Berlin, a partnership between DKFZ and Charité – Universitätsmedizin Berlin, Berlin, Germany
2Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
3Berlin Institute of Health (BIH), Berlin, Germany
4Department of Hematology, Oncology and Cancer Immunology (Campus Virchow Klinikum), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
5Max-Delbrück-Center, Berlin, Germany
6University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany
7Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
8Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany
9Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt/Main, Germany
10German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, a partnership between DKFZ and Goethe University, Frankfurt/Main, Germany

Jayastu Senapati, MD, DM, MBBS1, Hagop M. Kantarjian, MD1, Clark Robinson, MD2*, Koichi Takahashi, MD, PhD3, Nitin Jain, MD1, Fadi G. Haddad, MD1, Courtney D. DiNardo, MD, MSc4, Sanam Loghavi, MD5, Guilin Tang, MD, PhD5*, Guillermo Montalban-Bravo, MD1, Tapan M. Kadia, MD1, Naval Daver, MD6, Koji Sasaki, MD1, Zena Komrokji7*, Rebecca Garris1*, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MBBS8, Nicholas J. Short, MD1 and Elias Jabbour, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, MD Anderson, Saint Paul, MN
3Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston, TX
7Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
8Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Zuzanna Urbanska1,2*, Karolina Miarka-Walczyk, M.Sc.1*, Kamila Wypyszczak, M.Sc.1*, Borys Styka, M.Sc.3*, Monika Lejman, Ph.D.3*, Kinga Ostrowska, Ph.D.2*, Joanna Taha, Ph.D.2*, Zuzanna Nowicka, M.D.4*, Klaudia Starosz1*, Bartosz Urbanski, M.D.2*, Katarzyna Adamczewska-Wawrzynowicz, M.D., Ph.D.5*, Katarzyna Derwich, Prof., M.D., Ph.D.5*, Wojciech Fendler4*, Monika Mielcarek-Siedziuk, M.D., Ph.D.6*, Tomasz Szczepanski, Prof., M.D., Ph.D.7, Wojciech Mlynarski, Prof., M.D., Ph.D.2* and Agata Pastorczak, M.D., Ph.D.1,2*

1Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland
2Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland
3Laboratory of Genetic Diagnostics, Medical University of Lublin, Lublin, Poland
4Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland
5Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland
6Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Wroclaw, Poland
7Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland

Heye Yu1*, Wenbing Liu2*, Junping Zhang1*, Leling Xie1*, Anli Lai1*, Zheng Tian1*, Kejing Tang1*, Haiyan Xing1*, Wang Ying, M.D.1*, Hui Wei, MD3*, Qing Rao1*, Runxia Gu, MD1*, Min Wang1*, Huijun Wang3*, Jianxiang Wang, MD1 and Shaowei Qiu, MD1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Jason Xu1,2, Jonathan Sussman3*, Austin Yang4*, Satoshi Yoshimura, MD5*, Changya Chen2, Omar Elghawy, MD6*, Tiffaney Vincent, BS7*, Caroline Diorio, MD2, Shovik Bandyopadyay4*, Jianzhong Hu, BS8*, Alexander Lai Li9*, Gregory M. Chen, MD, PhD10*, Chia-Hui Chen11*, Rawan Shraim, PhD2*, Haley Newman, MD2, Yang Ding11, Elizabeth Li, MD12*, Wenbao Yu11*, Anusha Thadi9*, Kyung Jin Ahn4*, Petri Pölönen, PhD13, Abdelrahman Elsayed8*, David Frank, MD, PhD14*, Elizabeth A. Raetz, MD15, Mignon L. Loh, MD, PhD16, Brent L. Wood, MD, PhD17, Stuart S. Winter, MD18, Kimberly P. Dunsmore, MD19*, Meenakshi Devidas, PhD, MBA20, Chunxu Qu13*, Stanley Pounds, PhD21*, Stephen P. Hunger, MD22, Charles G. Mullighan, MBBS, MSc, MD13, Jun J. Yang, PhD5, Kai Tan, PhD23 and David T. Teachey, MD24

1Perelman School of Medicine, Philadelphia, PA
2Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
3Perelman School of Medicine, Philadelphia
4Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
5Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
6Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
7The Children's Hospital of Philadelphia, Philadelphia, PA
8St. Jude Children's Research Hospital, Memphis, TN
9Children's Hospital of Philadelphia, Philadelphia
10Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
11Children's Hospital of Philadelphia, Philadelphia, PA
12Children’s Hospital of Philadelphia, Philadelphia, PA
13Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
14Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA
15Department of Pediatrics, NYU Langone Health, New York, NY
16Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA
17Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
18Cancer and Blood Disorders, Children's Minnesota, Eagan, MN
19University of Virginia Health Sciences Center, Charlottesville, VA
20St Jude Children's Research Hospital, Memphis, TN
21Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
22Division of Oncology, Childrens Hospital of Philadelphia, Philadelphia
23Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
24Division of Oncology, Children's Hospital of Philadelphia, Rutledge, PA

Daniel Nguyen, MD, PhD1, Elias Jabbour, MD2, Nitin Jain, MD3, Omer Karrar4*, Cedric Nasnas, MD3*, Fadi G. Haddad, MD3, Jayastu Senapati, MD, DM, MBBS3, Tapan M. Kadia, MD3, Rebecca Garris3*, Hagop M. Kantarjian, MD1 and Nicholas J. Short, MD3

1University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX

Sudeepthi Bandikatla, MBBS, Moazzam Shahzad, MD, Bijal D Shah, MD and Todd C Knepper, PharmD*

H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Yang Zhang, MD1,2*, Ming Liu, MD1*, Xiaoli Ma, MD1*, Jiancheng Fang, MD1*, Fang Wang, MD1*, Xue Chen, MD1* and Hongxing Liu, MD1,2

1Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China

Jin Jung, PhD1,2*, Jae-Ho Yoon, MD, PhD3, Seok Lee, MD3, Ari Ahn, MD2*, Jong-Mi Lee, MD1,2*, Yonggoo Kim, MD1,2* and Myungshin Kim, MD1,2*

1Catholic Genetic Laboratory Center, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

*signifies non-member of ASH